NEW YORK, Feb. 04, 2026 (GLOBE NEWSWIRE) -- Nasdaq (Nasdaq: NDAQ) today reported monthly volumes for January 2026 on its Investor Relations website. A data sheet showing this information can be found at: https://ir.nasdaq.com/financials/volume-statistics. About Nasdaq Nasdaq (Nasdaq: NDAQ) is a leading technology platform that powers the world’s economies. We architect the world’s most modern markets, power the innovation economy, and build trust in the financial system. We empower economic opportunity by ...

We came across a bullish thesis on Nasdaq, Inc. on Stay Invested’s Substack by Denis Gorbunov. In this article, we will summarize the bulls’ thesis on NDAQ. Nasdaq, Inc.'s share was trading at $98.71 as of January 28th. NDAQ’s trailing and forward P/E were 35.18 and 26.18 respectively according to Yahoo Finance. 10 Buzzing AI Stocks on Wall Street Photo by Pascal Bernardon on Unsplash Nasdaq, Inc. operates as a technology company that serves capital markets and other industries worldwide. NDAQ is levera ...

The proposal comes as 2026 is shaping up to be ‌one of ‌the busiest years for new and some big listings, including IPO plans from Elon ‌Musk's SpaceX and artificial intelligence startup Anthropic. Under the proposed "Fast Entry" rule, a newly Nasdaq-listed company whose market capitalization ranks among the top 40 current index constituents would be eligible for accelerated inclusion, with at least five trading days' notice and entry after 15 sessions. The company would be exempt from standard ‌seasoning a ...

Photographer: Michael Nagle/Bloomberg The owner of the Nasdaq 100 Index is proposing to speed up the inclusion of newly listed, large-cap firms in the widely followed equity benchmark as a flurry of technology giants are slated to go public this year. Dubbed as the “fast entry” rule, the planned revision would allow a new listing to join the Nasdaq 100 after the first 15 trading days, Nasdaq said in a statement. That’s way shorter than the current waiting period of at least three months. Most Read from ...

Core Insights - Nasdaq has been selected by Osaka Exchange (OSE) to provide advanced Eqlipse Trading and Market Surveillance technology platforms, marking a significant step in OSE's modernization efforts and enhancing Japan's competitiveness in the global derivatives market [1][2][3] Group 1: Technology Partnership - The partnership with Nasdaq is expected to strengthen OSE's derivatives trading foundation, providing a safer and more efficient trading environment for all market stakeholders [2] - Nasdaq's technology will enable OSE to rapidly deploy new products and services, efficiently manage volume fluctuations, and maintain high performance standards [2][5] Group 2: Market Integrity and Performance - The integration of Nasdaq Market Surveillance technology will enhance OSE's market integrity framework, utilizing advanced analytics and AI to detect potential market abuse [6] - The Eqlipse Trading platform will support multi-asset trading with ultra-low latency, providing robust risk management tools and market-standard APIs [5] Group 3: Commitment to Modernization - OSE's modernization program reflects a commitment to world-class market infrastructure that adapts to evolving market dynamics while ensuring operational excellence [4][8] - Nasdaq's long-standing partnership with Japan's financial services ecosystem underscores its role in supporting the modernization and growth of Japan's capital markets [7][8] Group 4: Global Technology Leadership - Nasdaq's technology is utilized by major global financial institutions, including systematically important banks and stock exchanges, showcasing its leadership in market infrastructure [10]

Core Viewpoint - Adial Pharmaceuticals, Inc. will implement a 1-for-25 reverse stock split to comply with Nasdaq's minimum bid price requirement and enhance its capital markets profile [1][3][4] Group 1: Reverse Stock Split Details - The reverse stock split will reduce the number of outstanding shares from approximately 27.8 million to about 1.1 million, while maintaining the ownership percentage of each shareholder [2] - The reverse stock split will take effect on February 5, 2026, at 11:59 p.m. Eastern Time, with trading on a split-adjusted basis starting February 6, 2026 [1][2] - There will be no change to the total number of authorized shares as per the Company's Certificate of Incorporation [2] Group 2: Strategic Intentions - The reverse stock split aims to bring the Company into compliance with Nasdaq's minimum bid price requirement of at least $1.00 per share [3] - The action is expected to make the bid price more attractive to a wider range of institutional and retail investors [3][4] - The Company remains optimistic about its future and is focused on advancing its lead product, AD04, for the treatment of Alcohol Use Disorder [4][5] Group 3: Company Overview - Adial Pharmaceuticals is a clinical-stage biopharmaceutical company focused on developing therapies for addiction and related disorders [5] - The lead investigational drug, AD04, is a genetically targeted serotonin-3 receptor antagonist aimed at treating Alcohol Use Disorder in heavy drinking patients [5] - The Company plans to conduct a new Phase 3 clinical trial program for AD04, which has shown promising results in reducing drinking without significant safety concerns [5]

Core Viewpoint - Morgan Stanley analyst Michael Cyprys has raised the price target on Nasdaq (NDAQ) to $116 from $113 while maintaining an Overweight rating on the shares, indicating a positive outlook for the company [1]. Group 1: Revenue Growth - The firm anticipates that cyclical tailwinds will accelerate revenue growth across the Solutions business through 2026-27, suggesting a robust growth trajectory for Nasdaq [1]. - Durable underlying secular tailwinds are also expected to persist, further supporting the company's revenue potential [1].

Group 1 - Nasdaq, Inc. (NDAQ) has achieved a total return of almost 500% over the past 10 years, outperforming many other companies in the market [1] - The focus is on identifying companies with exceptional quality that can reinvest capital effectively for impressive returns, aiming for a long-term capital compounding capability [1] - A conservative investment strategy is primarily adopted, with occasional pursuit of opportunities that present a favorable risk-reward ratio, ensuring overall portfolio stability [1]

Group 1 - Nasdaq, Inc. (NDAQ) has achieved a total return of almost 500% over the past 10 years, outperforming many other companies in the market [1] - The focus is on identifying companies with exceptional quality that can reinvest capital for impressive returns, aiming for a long-term capital compounding capability [1] - A conservative investment strategy is primarily adopted, with occasional pursuit of opportunities that present a favorable risk-reward ratio [1]

Group 1 - The article does not provide any relevant content regarding company or industry insights [1]